Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 30, 2005 FBO #1161
SOLICITATION NOTICE

A -- RFPNIHNICHD200509

Notice Date
1/28/2005
 
Notice Type
Solicitation Notice
 
NAICS
541710 — Research and Development in the Physical, Engineering, and Life Sciences
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Child Health and Human Development, Contracts Management Branch 6100 Executive Blvd., Suite 7A07, MSC7510, Bethesda, MD, 20892-7510
 
ZIP Code
20892-7510
 
Solicitation Number
Reference-Number-RFP-NIH-NICHD-2005-09
 
Description
As part of its contract program for the Best Pharmaceuticals for Children Act (BPCA), the Centers for Research on Mothers and Children (CRMC) of the National Institute of Child Health and Human Development (NICHD) has a contract requirement to establish a Pediatric Off-Patent Drug Study (PODS) Center for the study of intravenous (IV) azithromycin in the treatment of Ureaplasma urealyticum colonization in preterm neonates in order to prevent Ureaplasma infection and the subsequent development of bronchopulmonary dysplasia. The NICHD already has awarded contracts for several other BPCA drug studies, including a contract for a BPCA Coordinating Center. Additional information on BPCA and NICHD can be found at http://www.nichd.nih.gov/oppb/bpca/index.htm. The Studies will include the following: (1)A single dose pharmacokinetic study, to characterize safety and tolerability in mechanically ventilated preterm neonates with Ureaplasma urealyticum endotracheal colonization at one, or more, clinically relevant doses; (2) Multiple-dose, exposure response study (ies), to assess the effect of two or more dose regimens of IV azithromycin on Ureaplasma urealyticum colonization of the respiratory tract of preterm neonates; and (3) Two studies that each assesses IV azithromycin efficacy and safety for the prevention of bronchopulmonary dysplasia in mechanically ventilated preterm neonatal patients with U. urealyticum endotracheal colonization. This contract requirement is classified as code 541710 under the North American Industry Classification System (NAICS). As such, the applicable Small Business Size Standard for this announcement is 500 employees. It is anticipated that one or more cost-reimbursement, incrementally funded completion-type contract(s), with a period of performance of 36 months, will be awarded as a result of the RFP. This announcement is not a Request for Proposals (RFP). It is anticipated that the RFP will be available on or before February 15, 2005 through the website at http://FedBizOpps.gov. All proposals must be submitted on or before the due date and time stated in the RFP to: Susan A. Nsangou, Contracting Officer, Contracts Management Branch, OAM, NICHD, 6100 Executive Boulevard, Suite 7A07, MSC 7510, Bethesda, Maryland, 20892-7510 (if sending by overnight carrier, use 6l00 Executive Boulevard, Suite 7A07, Rockville Maryland, 20852). The reference number to be used for this announcement is: RFP-NIH-NICHD-2005-09. All correspondence must cite the reference number as provided. Questions may be directed by telephone to Susan A. Nsangou, Contracting Officer, at (301) 435-8867. The Government does not intend to release hard copies of the RFP. The Government also reserves the right to cancel this procurement at any time prior to contract award.
 
Record
SN00741954-W 20050130/050128211819 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.